טוען...
Hypertrophic cardiomyopathy: The need for randomized trials
Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition characterized by variable degrees of asymmetric left ventricular (LV) hypertrophy, generally associated with mutations in sarcomere protein genes. While generally perceived as rare, HCM is the most common genetic heart disease with ove...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Bloomsbury Qatar Foundation Journals
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3963756/ https://ncbi.nlm.nih.gov/pubmed/24689025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5339/gcsp.2013.31 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|